| 000 | 01847 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515170906.0 | ||
| 264 | 0 | _c20091023 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a1530-6860 | ||
| 024 | 7 |
_a10.1096/fj.09-131383 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRiccio, Gennaro | |
| 245 | 0 | 0 |
_aCardiotoxic effects, or lack thereof, of anti-ErbB2 immunoagents. _h[electronic resource] |
| 260 |
_bFASEB journal : official publication of the Federation of American Societies for Experimental Biology _cSep 2009 |
||
| 300 |
_a3171-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xcomplications |
| 650 | 0 | 4 | _aCardiotoxins |
| 650 | 0 | 4 |
_aDNA Fragmentation _xdrug effects |
| 650 | 0 | 4 | _aDrug-Related Side Effects and Adverse Reactions |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 |
_aFibrosis _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aProtein Engineering _xmethods |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _ximmunology |
| 650 | 0 | 4 | _aTrastuzumab |
| 700 | 1 | _aEsposito, Giovanni | |
| 700 | 1 | _aLeoncini, Emanuela | |
| 700 | 1 | _aContu, Riccardo | |
| 700 | 1 | _aCondorelli, Gianluigi | |
| 700 | 1 | _aChiariello, Massimo | |
| 700 | 1 | _aLaccetti, Paolo | |
| 700 | 1 | _aHrelia, Silvana | |
| 700 | 1 | _aD'Alessio, Giuseppe | |
| 700 | 1 | _aDe Lorenzo, Claudia | |
| 773 | 0 |
_tFASEB journal : official publication of the Federation of American Societies for Experimental Biology _gvol. 23 _gno. 9 _gp. 3171-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1096/fj.09-131383 _zAvailable from publisher's website |
| 999 |
_c18845878 _d18845878 |
||